XML 46 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Income (Unaudited) (USD $)
In Thousands, except Per Share data, unless otherwise specified
 3 Months Ended 6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Jun. 30, 2011
Net sales $ 510,422 $ 521,656 $ 996,699 $ 1,006,777
Cost of goods sold 222,522 228,520 430,217 436,030
Gross profit 287,900 293,136 566,482 570,747
Selling, general and administrative expense 162,256 176,740 333,549 344,503
Research and development expense 52,336 48,210 105,259 90,940
Segment profit (loss) 73,308 68,186 127,674 135,304
Interest expense 12,401 12,041 25,597 28,807
Foreign exchange losses, net 1,619 2,744 3,060 5,786
Other (income) expense, net (6,731) (4,418) (13,181) (5,369)
Income before income taxes 66,019 57,819 112,198 106,080
Provision for income taxes (17,454) (17,797) (32,689) (33,120)
Net income including noncontrolling interests 48,565 40,022 79,509 72,960
Net loss (income) attributable to noncontrolling interests (222) 26 (161) 127
Net income attributable to Bio-Rad $ 48,343 $ 40,048 $ 79,348 $ 73,087
Basic earnings per share:        
Net income per share basic attributable to Bio-Rad $ 1.71 $ 1.43 $ 2.81 $ 2.61
Weighted average common shares - basic 28,250 28,014 28,226 27,959
Diluted earnings per share:        
Net income per share diluted attributable to Bio-Rad $ 1.69 $ 1.41 $ 2.78 $ 2.57
Weighted average common shares - diluted 28,610 28,495 28,582 28,443